Scopus BioPharma Inc.
SCPSDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001772028
Scopus BioPharma Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Nov 26, 2021; 15 institutions reported holding it in 13F filings for Q3 2022, worth $110.6K in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Scopus BioPharma Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +7 vs. Q3 2021
- Shares held
- 2.88M
- +2.61M (+947.5%) vs. Q3 2021
- Total value
- $4.71M
- +$3.57M (+313.3%) vs. Q3 2021
- New holders
- 8
- 5 more added
- Sold out
- 1
- 4 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCPS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 1 | $7.49K |
| Q3 2022 | 15 | $110.6K |
| Q2 2022 | 17 | $293.0K |
| Q1 2022 | 19 | $693.0K |
| Q4 2021 | 21 | $4.71M |
| Q3 2021 | 14 | $1.14M |
| Q2 2021 | 15 | $1.07M |
| Q1 2021 | 28 | $4.89M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Scopus BioPharma Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 63 | $0 | 0.00% | +14+28.6% | Added |
| Harbour Investments, Inc. | 1,000 | $2.00K | 0.00% | −475−32.2% | Reduced |
| Royal Bank of Canada | 1,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Compagnie Lombard Odier SCmA | 4,360 | $7.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 5,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,840 | $8.00K | 0.00% | +4,740+4,740.0% | Added |
| Tower Research Capital LLC (TRC) | 5,737 | $9.00K | 0.00% | −16,981−74.7% | Reduced |
| Northern Trust Corp | 12,516 | $20.0K | 0.00% | +12,516 | New |
| Virtu Financial LLC | 15,031 | $25.0K | 0.00% | +15,031 | New |
| BlackRock Inc. | 19,528 | $32.0K | 0.00% | +510+2.7% | Added |
| State Street Corp | 19,900 | $33.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 20,900 | $34.0K | 0.00% | +20,900 | New |
| Citadel Advisors LLC | 20,897 | $34.0K | 0.00% | +20,897 | New |
| First Manhattan Co | 25,800 | $42.0K | 0.00% | −2,000−7.2% | Reduced |
| Millennium Management LLC | 27,043 | $44.0K | 0.00% | −74,611−73.4% | Reduced |
| Two Sigma Investments, LP | 30,403 | $50.0K | 0.00% | +30,403 | New |
| Morgan Stanley | 44,012 | $72.0K | 0.00% | +43,012+4,301.2% | Added |
| Geode Capital Management, LLC | 66,121 | $108.0K | 0.00% | +66,121 | New |
| Bridgeway Capital Management, LLC | 93,966 | $154.0K | 0.00% | +23,100+32.6% | Added |
| Vanguard Group Inc | 363,041 | $594.0K | 0.00% | +363,041 | New |
| Armistice Capital, LLC | 2,100,000 | $3.43M | 0.08% | +2,100,000 | New |
| FMR LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |